Efavirenz use during pregnancy and for women of child-bearing potential

<p>Abstract</p> <p>Background</p> <p>Efavirenz is the preferred non-nucleoside reverse transcriptase inhibitor for first-line antiretroviral treatment in many countries. For women of childbearing potential, advantages of efavirenz are balanced by concerns that it is teratogenic. This paper reviews e...

Descripció completa

Dades bibliogràfiques

Autors principals:	Gray Glenda E, Krause Amanda, Wessels Tina, Venter Francois WD, Urban Michael F, Chersich Matthew F, Luchters Stanley, Viljoen Dennis L
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2006-04-01
Col·lecció:	AIDS Research and Therapy
Accés en línia:	http://www.aidsrestherapy.com/content/3/1/11
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!